Related references
Note: Only part of the references are listed.CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest
Shom Goel et al.
TRENDS IN CELL BIOLOGY (2018)
Expanding metabolic pathway for de novo biosynthesis of the chiral pharmaceutical intermediate L-pipecolic acid in Escherichia coli
Hanxiao Ying et al.
MICROBIAL CELL FACTORIES (2017)
Recent advances in engineering nonribosomal peptide assembly lines
M. Winn et al.
NATURAL PRODUCT REPORTS (2016)
Cyclic depsipeptides as potential cancer therapeutics
Jirouta Kitagaki et al.
ANTI-CANCER DRUGS (2015)
Ulleungamides A and B, Modified α,β-Dehydropipecolic Acid Containing Cyclic Depsipeptides from Streptomyces sp KCB13F003
Sangkeun Son et al.
ORGANIC LETTERS (2015)
Isolation and Structures of Pipecolidepsins A and B, Cytotoxic Cyclic Depsipeptides from the Madagascan Sponge Homophymia lamellosa
Laura Coello et al.
JOURNAL OF NATURAL PRODUCTS (2014)
Molecular Regulation of Antibiotic Biosynthesis in Streptomyces
Gang Liu et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2013)
Romidepsin (depsipeptide) induced cell cycle arrest, apoptosis and histone hyperacetylation in lung carcinoma cells (A549) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression
Radhakrishnan Vinodhkumar et al.
BIOMEDICINE & PHARMACOTHERAPY (2008)
RB and cell cycle progression
C. Giacinti et al.
ONCOGENE (2006)
Depsipeptide (FR 901228) promotes histone acetylation, gene transcription, apoptosis and its activity is enhanced by DNA methyltransferase inhibitors in AML1/ETO-positive leukemic cells
MI Klisovic et al.
LEUKEMIA (2003)
Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: An update
C Soldani et al.
APOPTOSIS (2002)
Share Paper
